S.G. Hymowitz
125 works · 15,514 citations · h-index 51
Top works
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
- IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding
- Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
- Triggering Cell Death
- Two-Amino Acid Molecular Switch in an Epithelial Morphogen That Regulates Binding to Two Distinct Receptors
- Therapeutic antibody targeting of individual Notch receptors
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
- A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAIL
- Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
- Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208
- Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
- K11-Linked Polyubiquitination in Cell Cycle Control Revealed by a K11 Linkage-Specific Antibody
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation
- Receptor-selective Mutants of Apoptosis-inducing Ligand 2/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Reveal a Greater Contribution of Death Receptor (DR) 5 than DR4 to Apoptosis Signaling
- A20: from ubiquitin editing to tumour suppression
- Structures of APRIL-Receptor Complexes
- Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2